Notice: Prescription Drug List (PDL): Hydrocortisone
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for hydrocortisone on the Prescription Drug List (PDL). Only the Human part of the PDL is to be revised; the listing for Veterinary use will remain unchanged.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-09-30
Data overview
- Formats
- HTML
- File languages
- English, French